Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled, phase 3 trial

Autor: Achim Fleischmann, Cindy Mak, Jane Hill, David Littlejohn, Andreas Veronesi, Holger Moch, Stefano Zurrida, L Perey, Nirmala Pathmanathan, Carlo Tondini, Giancarlo Pruneri, Viviana Galimberti, Christian Oehlschlegel, Christoph Rageth, Jack Hoffmann, Richard D. Gelber, John J. Collins, Angelo Recalcati, Marisa Donatella Magri, Andrée Rorive, Bruno Späti, Dimitri Sarlos, Zsuzsanna Varga, Rolf A. Stahel, Mattia Intra, Charlotte Lanng, P. Smart, L. Tan, Anna Cardillo, Francesco Coran, James French, Rudolf Maibach, Manuela Rabaglio, Marco Colleoni, Emilia Montagna, Elisabeth Saurenmann, Elisabeth Elder, Michael Knauer, Samuele Massarut, Mauro Arcicasa, Karin Ribi, Julie Craik, Theresa Zielinski, Wendy Jeanneret Sozzi, Sandro Morassut, Tiziana Rusca, Paul Chin, Elgene Lim, Frances M. Boyle, Richard West, Patrizia Dell'Orto, Umberto Veronesi, Marie-Christine Mathieu, Jean-Remi Garbay, Katrina Moore, Marisa Cristina Leonardi, Gregory Bruce Mann, Donatella Santini, Mario Roncadin, Joëlle Collignon, Michael D. Green, David Moon, Oreste Gentilini, Petere G. Gill, Stephen Allpress, Giulia Peruzzotti, Elga Majdic, Caitlin Mahoney, Karen N. Price, Craig Murphy, Lori Hayes, Melissa Bochner, Lynette Mann, Christoph Tausch, Otto Schiltknecht, Antonino Carbone, Aron Goldhirsch, Giuseppe Cancello, Anand Murugasu, John F. Forbes, Erica Piccoli, Luca Mazzucchelli, Alberto Gianatti, Lucien Zaman, Jose Manuel Cotrina, Per Karlsson, Janez Zgajnar, Diana Crivellari, Birgitte Bruun Rasmussen, Elisabetta Candiago, Manuela Sargenti, Robert Whitfield, Silvia Dellapasqua, R. Ghisini, Meredith M. Regan, Michael Müller, Tiziana Perin, M. Thorburn, Stamatina Fournarakou, Monika Bamert, Malcolm Buchanan, Allison Jones, Gerhard Ries, Andreas Ehrsam, Hugh Carmalt, István Láng, Jürg Bernhard, Guy Jerusalem, Manuela Lagrassa, S. Fiona Bonar, Mario Mileto, Jurij Lindtner, P. Jeal, Fereshte Farshidi, Bernard F. Cole, John Hoerby, James Kollias, Privato Fenaroli, Giovanni Mazzarol, Richard Dyer, Angelo Buonadonna, Heidi Roschitzki, Stefania Andrighetto, Robert Macindoe, Martin F. Fey, Ingrid Kössler, Olivia Pagani, Anita Hiltbrunner, Camelia Chifu, William Ross, Rachele Volpe, Linda Leidi, Barbara Ruepp, Giorgio Caccia, Philippe Delvenne, Susanne Gerred, Tara Scolese, Mario Taffurelli, Paola Baratella, Jean Francois Delaloye, Richard Harman, A. Michael Bilous, Ian G. Campbell, Franco Nolè, Maryse Fiche, Ute Lorenz, Susanne Roux, Roberto Orecchia, Mark Sywak, Aashit Shah, Assia Treboux, Laura Cattaneo, Martina Egli-Tupaj, Rosmarie Caduff, Paolo Veronesi, Linda Madigan, Elena Kralidis, Maj-Lis Moeller Talman, Roswitha Kammler, Michael Töpfer, Eva Juhasz, Peer Schousen, Michele Ghielmini, Snjezana Frkovic-Grazio, Hanne Galatius, Elisabeth Rippy, Sylvie Maweja, Lynette Blacher, Stefan Aebi, D.F. Preece, Gilles Berclaz, Daniel Wyss, D. F. Lindsay, Andreas Günthert, Frederick Mayall, Lucia Bronz, Paul McKenzie, Andrew J. Spillane, Giuseppe Viale, Sandra Lippert, Alberto Luini, Virginia Howard, Giuseppe Curigliano, Rainer Grobholz, Robert Millar, Julio Abugattas, Hans-Anton Lehr, Maria Emanuela Limonta, Monica Iorfida, Elisa Vicini, Helle Holtveg, Angelo Di Leo, Giuseppe Renne, Alan S. Coates, Ezio Candiani, Karolyn Scott, Mauro G. Mastropasqua, Paolo Tricomi, Thomas Gyr, Karen Briscoe

Summary Background We previously reported the 5-year results of the phase 3 IBCSG 23-01 trial comparing disease-free survival in patients with breast cancer with one or more micrometastatic (≤2 mm) sentinel nodes randomly assigned to either axillar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f23104b9fbd9c5bf4b71a7ff92c0181c
http://hdl.handle.net/11585/700780